Results 121 to 130 of about 14,082 (161)

Canada's 2025 AMR priority pathogens: Evidence-based ranking and public health implications. [PDF]

PLoS One
Abdesselam K, Ngendabanka RJ, Muchaal PK, Amaratunga K, Mishra A, Narkar R, Crago AL, Lary T.   +7 more
europepmc   +1 more source

Engineering <i>Yarrowia lipolytica</i> as a yeast cell factory for the de novo production of poly(3-hydroxybutyrate-co-4-hydroxybutyrate). [PDF]

Synth Syst Biotechnol
Liu J, Yan J, Cui Z, Qi Q.
europepmc   +1 more source

Hospitalizations associated with endemic and non-endemic mosquito-borne arboviruses in Canada, 2002-2023. [PDF]

PLoS One
Mitri ME, Ludwig A, Tataryn J, Gasmi S, Whitlock M, Buck PA, Bourgeois AC.   +6 more
europepmc   +1 more source

Monitoring proliferation and material production of Cupriavidus necator H16 using cell count and volume measurement. [PDF]

Sci Rep
Kamasaka K, Abekawa N, Takeda K, Noi K, Matsuda M, Matsumoto K, Yumoto N, Kondo A, Hasunuma T.   +8 more
europepmc   +1 more source

Release notice - Updated child protection legislation review with focus on Indigenous rights and data sharing, Canada. [PDF]

Health Promot Chronic Dis Prev Can
europepmc   +1 more source

Management of anaphylaxis. [PDF]

CMAJ
Jeimy S, Huan PW, Abrams E.
europepmc   +1 more source

Enhanced production of recombinant proteins with by deletion of insertion sequences (IS elements) [PDF]

core   +1 more source

Furin as target for suppression of mosquito-borne viruses. [PDF]

Virol J
Centurión A, Omokungbe B, Oberpaul M, Dersch L, Stiehler S, Chambers C, Lechner M, Lüddecke T, Vilcinskas A, Steinmetzer T, Hardes K.   +10 more
europepmc   +1 more source

Divergent Synthesis and Crystal Engineering of Room-Temperature Phosphorescent Carbonyl-Bridged Triphenylamines. [PDF]

Angew Chem Int Ed Engl
Ruchlin C, Castillo-Pazos DJ, Lasso JD, Hamzehpoor E, Mikov A, Li CJ, Perepichka DF.   +6 more
europepmc   +1 more source

National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada. [PDF]

Vaccines (Basel)
MacTavish R, Slatculescu A, Ermacora D, Vukovojac K, Noth T, Ward N, Laskoski K, Fleming D, Manoharan B, Laroche J, Fall A.   +10 more
europepmc   +1 more source